Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer

Abstract

The pretreatment NLR and PLR might be beneficial to predict the progression and prognosis of PCa. Furthermore, NLR was more effective than PLR acting as an independent prognostic indicator for PCa.